22 Sep 2015

Constraints on global supply of BCG vaccine

The WHO has called on all countries to take action to reduce wastage and ensure that high risk groups are prioritised Constraints on global supply of BCG vaccine

Due to on-going constraints with the global supply of BCG vaccine, the World Health Organization (WHO) has called on all countries to reduce BCG vaccine wastage [1], to ensure that countries with the highest TB rates receive priority and to target individuals who will benefit most from BCG vaccination. The WHO statement can be accessed here.

Providers of BCG vaccine are encouraged to organise the administration of BCG vaccinations in ways that optimise the use of the current multi-dose vials, for example by scheduling patients requiring BCG into the same clinic. Public Health England (PHE) supports the WHO statement to limit BCG vaccination to neonates and infants of recognised high-risk groups for tuberculosis or to tuberculin-negative children under five years of age. For further information on priority groups please check PHE guidance.


Nigeria: yellow fever outbreaks

Suspected and confirmed cases of yellow fever reported to the World Health Organization Read more

Measles in Europe

A reminder for seasonal travellers to ensure they are up to date with measles vaccine Read more

Diphtheria in the Caribbean and South America

A reminder for travellers to be up to date with diphtheria vaccine Read more

Polio: Public Health Emergency of International Concern

An update on the polio Public Health Emergency of International Concern (PHEIC) Read more

Hepatitis B vaccine shortage and vaccine prioritisation: advising the traveller

Public Health England and NaTHNaC update the temporary recommendations for hepatitis B containing vaccine use in children and adults travelling to countries of intermediate/high prevalence Read more
Back to Top